InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DGA | Ann: Suspension (COB 27/03/2015) and Removal from Trading Status | 02/02/15 | 0 | 282 | |||
|
|||||||
DGA | Ann: DGA Notice of Termination | 29/01/15 | 0 | 212 | |||
|
|||||||
DGA | Ann: DGA NAV AND UNITS ON ISSUE | 09/12/14 | 0 | 254 | |||
|
|||||||
DGA | Ann: DGA NAV AND UNITS ON ISSUE | 11/11/14 | 0 | 280 | |||
|
|||||||
DGA | Ann: DGA NAV AND UNITS ON ISSUE | 09/10/14 | 0 | 285 | |||
|
|||||||
DGA | Ann: ANNUAL REPORT TO SHAREHOLDERS | 29/09/14 | 0 | 229 | |||
|
|||||||
DGA | Ann: DGA NAV AND UNITS ON ISSUE | 08/09/14 | 0 | 256 | |||
|
|||||||
DGA | Ann: DGA NAV AND UNITS ON ISSUE | 05/08/14 | 0 | 319 | |||
|
See All Discussions